Fasinumab
Product Specifications
CAS Number
1190239-42-9
Target
Trk receptor
Related Pathways
Tyrosine Kinase/Adaptors
Purity
0.997
Bioactivity
Fasinumab (Anti-Human NGF), a human IgG1κ monoclonal antibody targeting nerve growth factor (NGF), can be used in studies about acute sciatica and knee osteoarthritis (OA) . clinical research has demonstrated that Fasinumab achieves statistically significant improvements in both pain and physical function scores when compared to a placebo control group.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog